Effects of the nonsteroidal anti-inflammatory drug piroxicam on energy metabolism in the perfused rat liver. 1996

C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
Department of Biochemistry, University of Maringá, Brazil.

1. The actions of piroxicam, a nonsteroidal and noncarboxylic anti-inflammatory drug, on the metabolism of the isolated perfused rat liver were investigated. The main purpose was to verify if piroxicam is also active on glycogenolysis and energy metabolism, as demonstrated for several carboxylic nonsteroidal anti-inflammatories. 2. Piroxicam increased oxygen consumption in livers from both fed and fasted rats. 3. Piroxicam increased glucose release and glycolysis from endogenous glycogen (glycogenolysis). 4. Gluconeogenesis from lactate plus pyruvate was inhibited. 5. The action of piroxicam on oxygen consumption was blocked by antimycin A, but not by atractyloside. 6. The action of piroxicam in the perfused rat liver metabolism seems to be a consequence of its action on mitochondria. 7. It can be concluded that inhibition of energy metabolism and stimulation of glycogenolysis are not specific properties of carboxylic nonsteroidal anti-inflammatory drugs.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D009243 NAD A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) Coenzyme I,DPN,Diphosphopyridine Nucleotide,Nadide,Nicotinamide-Adenine Dinucleotide,Dihydronicotinamide Adenine Dinucleotide,NADH,Adenine Dinucleotide, Dihydronicotinamide,Dinucleotide, Dihydronicotinamide Adenine,Dinucleotide, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide,Nucleotide, Diphosphopyridine
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010894 Piroxicam A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. CP-16171,Feldene,CP 16171,CP16171
D011773 Pyruvates Derivatives of PYRUVIC ACID, including its salts and esters.

Related Publications

C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
March 1989, Biochemical pharmacology,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
January 1996, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
January 1987, Cutis,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
January 1998, Research communications in molecular pathology and pharmacology,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
July 2003, The Journal of clinical psychiatry,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
September 1974, European journal of biochemistry,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
July 2015, Toxicology letters,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
January 1996, Diseases of the colon and rectum,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
January 2018, Biological & pharmaceutical bulletin,
C L Salgueiro-Pagadigorria, and J Constantin, and A Bracht, and E A Nascimento, and E L Ishii-Iwamoto
January 2005, Digestive diseases and sciences,
Copied contents to your clipboard!